Wufu Zhu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Tyrosine Kinase

Ulcerative Colitis

Epidermal Growth Factor Receptor

Lipopolysaccharide Induced

Top Venues

Journal of medicinal chemistry

Archiv der Pharmazie

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Xuan Zhang, Jie He, Shidi Xu, Li Fu, Pengwu Zheng, Shan Xu, Qingshan Pan, Wufu Zhu
Insights into the Overcoming EGFR Del19/T790M/C797S Mutation: A Perspective on the 2-aryl-4-aminothienopyrimidine Backbone. ChemMedChem (2024)
Yu Zou, Xiemin Wang, Pan Chen, Zhiwei Zheng, Xiaobo Li, Zhichao Chen, Mi Guo, Ying Zhou, Chenhui Sun, Ran Wang, Wufu Zhu, Pengwu Zheng, Won-Jea Cho, Young-Chang Cho, Guang Liang, Qidong Tang
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury. Journal of medicinal chemistry 67 (13) (2024)
Yu Zou, Xiemin Wang, Pan Chen, Zhiwei Zheng, Xiaobo Li, Zhichao Chen, Mi Guo, Ying Zhou, Chenhui Sun, Ran Wang, Wufu Zhu, Pengwu Zheng, Won-Jea Cho, Young-Chang Cho, Guang Liang, Qidong Tang
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury. Journal of medicinal chemistry (2024)
Xuan Zhang, Jie He, Shidi Xu, Li Fu, Pengwu Zheng, Shan Xu, Qingshan Pan, Wufu Zhu
Insights into the Overcoming EGFR Del19/T790M/C797S Mutation: A Perspective on the 2-Aryl-4-aminothienopyrimidine Backbone. ChemMedChem 19 (9) (2024)
Yu Zou, Xiemin Wang, Pan Chen, Zhiwei Zheng, Xiaobo Li, Zhichao Chen, Mi Guo, Ying Zhou, Chenhui Sun, Ran Wang, Wufu Zhu, Pengwu Zheng, Won-Jea Cho, Young-Chang Cho, Guang Liang, Qidong Tang
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury. Journal of medicinal chemistry 67 (13) (2024)
Yu Zou, Xiemin Wang, Pan Chen, Zhiwei Zheng, Xiaobo Li, Zhichao Chen, Mi Guo, Ying Zhou, Chenhui Sun, Ran Wang, Wufu Zhu, Pengwu Zheng, Won-Jea Cho, Young-Chang Cho, Guang Liang, Qidong Tang
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury. Journal of medicinal chemistry (2024)
Anqi Li, Yan Zhang, Li Wan, Rujue Peng, Xuan Zhang, Qiuyan Guo, Shan Xu, Dan Qiao, Pengwu Zheng, Na Li, Wufu Zhu, Qingshan Pan
Coordination-Driven Self-Assembly of Metal Ion-Antisense Oligonucleotide Nanohybrids for Chronic Bacterial Infection Therapy. ACS applied materials & interfaces 16 (22) (2024)
Xuan Zhang, Jie He, Shidi Xu, Li Fu, Pengwu Zheng, Shan Xu, Qingshan Pan, Wufu Zhu
Insights into the Overcoming EGFR Del19/T790M/C797S Mutation: A Perspective on the 2-Aryl-4-aminothienopyrimidine Backbone. ChemMedChem 19 (9) (2024)
Anqi Li, Yan Zhang, Li Wan, Rujue Peng, Xuan Zhang, Qiuyan Guo, Shan Xu, Dan Qiao, Pengwu Zheng, Na Li, Wufu Zhu, Qingshan Pan
Coordination-Driven Self-Assembly of Metal Ion-Antisense Oligonucleotide Nanohybrids for Chronic Bacterial Infection Therapy. ACS applied materials & interfaces (2024)
Chunping Wen, Yan Zhang, Luogen Lai, Xuan Zhan, Yijun Li, Qiuyan Guo, Rujue Peng, Yating Ga, Xufei Zhang, Yan He, Shan Xu, Dan Qia, Pengwu Zheng, Qingshan Pan, Wufu Zhu
Photothermally Enhanced Cascaded Nanozyme-Functionalized Black Phosphorus Nanosheets for Targeted Treatment of Infected Diabetic Wounds. Advanced healthcare materials (2023)
Shidi Xu, Zhihui Zhou, Jie He, Jiaojiao Guo, Xiaoling Huang, Yufeng An, Qingshan Pan, Shan Xu, Wufu Zhu
Novel bioactive 2-phenyl-4-aminopyrimidine derivatives as EGFR Del19/T790M/C797S inhibitors for the treatment of non-small cell lung cancer. Archiv der Pharmazie (2023)
Yang Yang, Xin Sun, Leixuan Luo, Rujue Peng, Ruiqing Yang, Zhenjie Cheng, Yao Lv, Hongfeng Li, Qidong Tang, Wufu Zhu, Dan Qiao, Shan Xu
Discovery of novel potent PI3K/mTOR dual-target inhibitors based on scaffold hopping: Design, synthesis, and antiproliferative activity. Archiv der Pharmazie (2023)
Jie He, Leixuan Luo, Shidi Xu, Feiyi Yang, Wufu Zhu
Pyrrole-based EGFR inhibitors for the treatment of NCSLC: Binding modes and SARs investigations. Chemical biology & drug design (2022)
Yan Zhang, Luogen Lai, Yijun Liu, Beini Chen, Jing Yao, Pengwu Zheng, Qingshan Pan, Wufu Zhu
Biomineralized Cascade Enzyme-Encapsulated ZIF-8 Nanoparticles Combined with Antisense Oligonucleotides for Drug-Resistant Bacteria Treatment. ACS applied materials & interfaces 14 (5) (2022)
Luogen Lai, Qinqin Wang, Binliang Zhang, Zhen Xiao, Zunhua Yang, Qi Yang, Zixin Luo, Wufu Zhu, Shan Xu
Synthesis and bioevaluation of thienopyrimidines bearing a pyrazoline unit as selective PI3Kα inhibitors. RSC advances 9 (51) (2019)
Linxiao Wang, Xiaobo Liu, Yongli Duan, Xiaojing Li, Bingbing Zhao, Caolin Wang, Zhen Xiao, Pengwu Zheng, Qidong Tang, Wufu Zhu
Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors. Chemical biology & drug design 92 (1) (2018)
Zhen Xiao, Fei Lei, Xiuying Chen, Xiaolei Wang, Lujie Cao, Kejun Ye, Wufu Zhu, Shan Xu
Design, synthesis, and antitumor evaluation of quinoline-imidazole derivatives. Archiv der Pharmazie 351 (6) (2018)